| Descriptor English: | Atazanavir Sulfate | ||||
| Descriptor Spanish: |
Sulfato de Atazanavir
| ||||
| Descriptor Portuguese: | Sulfato de Atazanavir | ||||
| Descriptor French: | Sulfate d'atazanavir | ||||
| Entry term(s): |
232632, BMS 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester Atazanavir BMS 232632 BMS 232632 05 BMS-232632 BMS-232632-05 BMS232632 BMS23263205 CGP 73547 CGP 75136 CGP 75176 CGP 75355 CGP-73547 CGP-75136 CGP-75176 CGP-75355 CGP73547 CGP75136 CGP75176 CGP75355 Reyataz |
||||
| Tree number(s): |
D03.383.725.068 D12.644.456.157 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000069446 | ||||
| Scope note: | An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
HIV Protease Inhibitors |
||||
| Registry Number: | 4MT4VIE29P | ||||
| Public MeSH Note: | 2016; ATAZANAVIR SULFATE was indexed under OLIGOPEPTIDES and PYRIDINES 2000-2015 |
||||
| History Note: | 2016 (2000) |
||||
| DeCS ID: | 55925 | ||||
| Unique ID: | D000069446 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2016/01/01 | ||||
| Date of Entry: | 2015/07/09 | ||||
| Revision Date: | 2016/07/11 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Atazanavir Sulfate
- Preferred
Reyataz
- Narrower
Atazanavir
- Broader
CGP 75176
- Narrower
CGP 73547
- Narrower
CGP 75355
- Narrower
CGP 75136
- Narrower
BMS-232632-05
- Narrower
BMS 232632
- Narrower
| Concept UI |
M0445555 |
| Scope note | An azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with other ANTI-HIV AGENTS. |
| Preferred term | Atazanavir Sulfate |
| Concept UI |
M0449395 |
| Preferred term | Reyataz |
| Concept UI |
M000616894 |
| Preferred term | Atazanavir |
| Entry term(s) |
3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-2,5,6,10,13-pentaazatetradecanedioic acid dimethyl ester |
| Concept UI |
M0460139 |
| Preferred term | CGP 75176 |
| Entry term(s) |
CGP-75176 CGP75176 |
| Concept UI |
M0460141 |
| Preferred term | CGP 73547 |
| Entry term(s) |
CGP-73547 CGP73547 |
| Concept UI |
M0460138 |
| Preferred term | CGP 75355 |
| Entry term(s) |
CGP-75355 CGP75355 |
| Concept UI |
M0460140 |
| Preferred term | CGP 75136 |
| Entry term(s) |
CGP-75136 CGP75136 |
| Concept UI |
M0460142 |
| Preferred term | BMS-232632-05 |
| Entry term(s) |
BMS 232632 05 BMS23263205 |
| Concept UI |
M0369941 |
| Preferred term | BMS 232632 |
| Entry term(s) |
232632, BMS BMS-232632 BMS232632 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey